Coastar Therapeutics

Coastar Therapeutics is a preclinical biotechnology company dedicated to developing bio-payload delivery technologies for cancer immunotherapy and gene therapy. Our proprietary ENHEnSTM technology can be used to coat bio-payloads with cell membranes, helping them evade recognition and clearance by the immune system, and successfully delivering them to tumors or other disease sites.